We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

57 hedge funds and large institutions have $233M invested in Aura Biosciences in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 12

16% more funds holding

Funds holding: 49 → 57 (+8)

0.27% more ownership

Funds ownership: 66.06% → 66.32% (+0.27%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less capital invested

Capital invested by funds: $250M → $233M (-$17.4M)

Holders
57
Holders Change
+8
Holders Change %
+16.33%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
24
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6M
2
Citigroup
Citigroup
New York
+$3.85M
3
BlackRock
BlackRock
New York
+$2.89M
4
EAM
Eventide Asset Management
Massachusetts
+$2.85M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.92M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$4.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.86M
3
Citadel Advisors
Citadel Advisors
Florida
-$2.44M
4
MIM
Monashee Investment Management
Massachusetts
-$1.38M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$297K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$381K +$144K +13,878 +51%
Barclays
27
Barclays
United Kingdom
$319K -$21.8K -2,102 -6%
TGAM
28
TBH Global Asset Management
Tennessee
$307K +$344K +33,097 New
Millennium Management
29
Millennium Management
New York
$290K +$325K +31,281 New
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$276K +$73.9K +7,117 +31%
AA
31
ALPS Advisors
Colorado
$220K -$7.15K -688 -3%
WIC
32
Water Island Capital
New York
$220K +$1.72K +166 +0.7%
Verition Fund Management
33
Verition Fund Management
Connecticut
$202K +$226K +21,772 New
MAM
34
Martingale Asset Management
Massachusetts
$189K +$211K +20,354 New
JP Morgan Chase
35
JP Morgan Chase
New York
$171K +$80.5K +7,752 +72%
Deutsche Bank
36
Deutsche Bank
Germany
$143K +$74.8K +7,203 +88%
LCS
37
Levin Capital Strategies
New York
$139K +$156K +15,000 New
Mariner
38
Mariner
Kansas
$129K +$145K +13,922 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$126K -$9.35K -900 -6%
Mirae Asset Global Investments
40
Mirae Asset Global Investments
South Korea
$108K +$121K +11,659 New
AIG
41
American International Group
New York
$106K +$28.5K +2,748 +32%
SG Americas Securities
42
SG Americas Securities
New York
$104K +$116K +11,201 New
MIM
43
MetLife Investment Management
New Jersey
$102K – – –
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$100K +$112K +10,800 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$96K +$107K +10,343 New
Renaissance Technologies
46
Renaissance Technologies
New York
$94K -$31.2K -3,000 -23%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$81.6K +$15.4K +1,478 +20%
VFA
48
Values First Advisors
Tennessee
$54.8K +$61.3K +5,902 New
Wells Fargo
49
Wells Fargo
California
$42.3K +$47.4K +4,561 New
AB
50
Amalgamated Bank
New York
$28K +$1.25K +120 +4%
1
2
3

AURA Hedge Fund Activity: Q1 2023 in Review

57 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q1 2023, worth a combined $233M — down 7% from $250M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AURA positions and 6 closed out — a net gain of 8 holders — while 24 added to existing stakes and 12 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $6M. The largest seller was Artal Group, exiting entirely with an estimated $4.3M sold.

  • 57 institutional investors held Aura Biosciences (AURA) as of Q1 2023, up from 49 in Q4 2022.
  • Funds reported $233M of Aura Biosciences stock for Q1 2023, down 7% quarter-over-quarter.
  • 14 funds opened new Aura Biosciences positions in Q1 2023 and 6 closed out, a net change of +8 holders.
  • The largest Aura Biosciences buyer in Q1 2023 was Adage Capital Partners, an estimated $6M added.
  • The largest Aura Biosciences seller in Q1 2023 was Artal Group, an estimated $4.3M sold.

Based on aggregated 13F filings for Q1 2023.